FDA Grants Accelerated Approval to OJEMDA (tovorafenib) as First Targeted Therapy for Pediatric Low-Grade Glioma
The United States Food and Drug Administration (FDA) has granted accelerated approval to OJEMDA (tovorafenib),...
Knowledge and News for the Global Fight Against Cancer.
The United States Food and Drug Administration (FDA) has granted accelerated approval to OJEMDA (tovorafenib),...
The groundbreaking discovery, spearheaded by investigators at Weill Cornell Medicine and published on March 14...
Scientific understanding of the indoor environment has undergone a paradigm shift following recent research led...
Small interfering RNA (siRNA) drugs represent a groundbreaking frontier in genetic medicine, offering the potential...
Researchers at the Karolinska Institutet and the Astrid Lindgren Children’s Hospital in Sweden have made...
A groundbreaking study by Ludwig Cancer Research has unveiled a pioneering strategy with the potential...
In a landmark achievement for the field of synthetic biology and genetics, an international consortium...
The landscape of pediatric oncology is currently witnessing a significant shift toward precision medicine and...
A groundbreaking study, spearheaded by researchers at the Johns Hopkins Kimmel Cancer Center Bloomberg~Kimmel Institute...
The decision to initiate hormone therapy (HT) during the menopause transition, a pivotal life phase...